Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus.
- 1 October 2001
- journal article
- review article
- Published by Informa UK Limited in Journal of the American College of Nutrition
- Vol. 20 (5), 370S-380S
- https://doi.org/10.1080/07315724.2001.10719170
Abstract
Despite significant achievements in treatment modalities and preventive measures, the prevalence of diabetes has risen exponentially in the last decade. Because of these limitations there is a continued need for new and more effective therapies. An increasing number of people are using dietary and herbal supplements, even though there is a general lack of evidence for their safety and efficacy. Consequently, science based medical and government regulators are calling for more randomized clinical studies to provide evidence of efficacy and safety. Our research group has selected two such promising and functionally complementary therapies for further investigation as potentially emerging alternative therapies for type 2 diabetes: Konjac-mannan (KJM) and American ginseng (AG). We have generated a mounting body of evidence to support the claim that rheologically-selected, highly-viscous KJM, and AG with a specific composition may be useful in improving diabetes control, reducing associated risk factors such as hyperlipidemia and hypertension, and ameliorating insulin resistance. KJM has a demonstrated ability to modulate the rate of absorption of nutrients from the small bowel, whereas AG has post-absorptive effects. Consequently, it appears that KJM and AG are acting through different, yet complementary, mechanisms: KJM by increasing insulin sensitivity and AG likely by enhancing insulin secretion. Before the therapeutic potential of KJM and AG as novel prandial agents for treatment of diabetes can be fully realized, further controlled trials with larger sample sizes and of longer duration are required. A determination of the active ingredients in AG, and the rheology-biology relationship of KJM are also warranted.Keywords
This publication has 43 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin SensitivityEndocrine Reviews, 1998
- Ginseng Therapy in Non-Insulin-Dependent Diabetic Patients: Effects on psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weightDiabetes Care, 1995
- Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose loadBritish Journal of Nutrition, 1994
- Nibbling versus Gorging: Metabolic Advantages of Increased Meal FrequencyNew England Journal of Medicine, 1989
- Isolation and Hypoglycemic Activity of Quinquefolans A,B, and C, Glycans of Panax quinquefolium RootsJournal of Natural Products, 1987
- Hypoglycemic constituents of Panax ginsengGeneral Pharmacology: The Vascular System, 1985
- Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.JCI Insight, 1985
- Antitumor activity of water-soluble .BETA.-D-glucan elaborated by Ganoderma applanatum.Agricultural and Biological Chemistry, 1981
- Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas.Journal of Pharmacobio-Dynamics, 1981